BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Liu P, Li ZM. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein. World J Gastroenterol 2008; 14(14): 2251-2254 [PMID: 18407604 DOI: 10.3748/wjg.14.2251]
URL: https://www.wjgnet.com/1007-9327/full/v14/i14/2251.htm
Number Citing Articles
1
Juan Hu, Wubo Ren, Han Liu, Cong Xie, Dandan Li, Liping Yang, Fangli Liao, Linshan Jiang, Qinli Pu, Weixian Chen. Immunomultiple PCR-based electrochemical and lateral flow strategy for the simultaneous detection of liver cancer tumor markersMicrochimica Acta 2024; 191(1) doi: 10.1007/s00604-023-06098-y
2
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_36-1
3
Xiaoming Gong, Tao Chen, Cheyu Lin, Haiqin Ping, Xin Tong, Kai Zhang, Zhaojun Chen, Caiyun Cai, Zhiyan Lu, Hengning Ke, Yunfeng Zhao. Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug ScreeningBioMed Research International 2023; 2023: 1 doi: 10.1155/2023/2501596
4
Bin Wang, Liang Chen, Hao-Teng Chang. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bileBiomarkers in Medicine 2016; 10(6): 613 doi: 10.2217/bmm-2015-0062
5
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-AnalysisBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
6
Xiaoyun Zhang, Yongjie Zhou, Zhenru Wu, Wei Peng, Chuan Li, Lvnan Yan, Jiayin Yang, Tianfu Wen. Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching AnalysisClinical and Translational Gastroenterology 2021; 12(11): e00425 doi: 10.14309/ctg.0000000000000425
7
Kailiang Zhao, Xiaoquan Zhou, Yuchun Xiao, Yanni Wang, Lu Wen. Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver CancerMini-Reviews in Medicinal Chemistry 2022; 22(17): 2237 doi: 10.2174/1389557522666220218124816
8
Jie Cao, Liang Huang, Caifeng Liu, Jing Li, Xianghua Zhang, Jun Shen, Jun Li, Lun Lu, Feng Xu, Jianjun Yan, Mengchao Wu, Wan Yee Lau, Yiqun Yan. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A clinicopathologic study of 35 resected casesJournal of Gastroenterology and Hepatology 2013; 28(6): 1025 doi: 10.1111/jgh.12143
9
Raynoo Thanan, Waleeporn Kaewlert, Chadamas Sakonsinsiri, Timpika Chaiprasert, Napat Armartmuntree, Duangkamon Muengsaen, Anchalee Techasen, Poramate Klanrit, Worachart Lert-itthiporn, Somchai Pinlaor, Chawalit Pairojkul. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma ProgressionInternational Journal of Molecular Sciences 2020; 21(5): 1796 doi: 10.3390/ijms21051796
10
Jennifer Mbamalu Chinenye, Mercy Ekejindu Ifeoma, Bessie Enweani-Nwokelo Ifeoma, Ikechukwu Okeke Obiefuna, Amaechi Ofodile Chukwudi, Okorafor Kalu Stephen. Frequency of hepatitis C and D virus among chronic hepatitis B virus carriers in a Nigerian tertiary hospitalJournal of Public Health and Epidemiology 2022; 14(1): 10 doi: 10.5897/JPHE2021.1367
11
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 699 doi: 10.1007/978-3-319-26956-6_36
12
Lian-Yuan Tao, Lei Cai, Xiao-Dong He, Wei Liu, Qiang Qu. Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular CarcinomaThe American Surgeon 2010; 76(11): 1210 doi: 10.1177/000313481007601119
13
Irene Y. Chen, Richard F. Dunne, Xiaoyan Liao. Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experienceVirchows Archiv 2024;  doi: 10.1007/s00428-024-03787-8
14
Álvaro Díaz-González, Alejandro Forner, María Reig, Jordi Bruix. Encyclopedia of Gastroenterology2020; : 151 doi: 10.1016/B978-0-12-801238-3.65714-8
15
Xin Zhang, Wen-Juan Huang, Meng-Lin Zhang, Wen Wang, Ye Niu, Rui-tao Wang, Zeng-yao Liu. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinomaBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02348-0
16
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma2013; : 111 doi: 10.1007/978-94-007-6473-6_10
17
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review)International Journal of Oncology 2020;  doi: 10.3892/ijo.2020.5035
18
Dengqiang Wu, Yujie Li. Application of adoptive cell therapy in hepatocellular carcinomaImmunology 2023; 170(4): 453 doi: 10.1111/imm.13677
19
Xiaoping Wang, Caifei Shen, Jianjiang Yang, Xianjun Yang, Sen Qin, Haijun Zeng, Xiaoling Wu, Shanhong Tang, Weizheng Zeng. Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver FailureCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/1232785
20
Johnathan Abou-Fadel, Victoria Reid, Alexander Le, Jacob Croft, Jun Zhang. Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic CancersDiagnostics 2023; 13(6): 1012 doi: 10.3390/diagnostics13061012
21
Meng-Meng Qu, Yuan-Hui Zhu, Yi-Xiang Li, Zhi-Fan Li, Jin-Kui Li, Yong-Sheng Xu, Manishkumar Shrestha, Jun-Qiang Lei. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinomaMedicine 2021; 100(46): e27349 doi: 10.1097/MD.0000000000027349
22
Zhizhen Li, Lei Yuan, Chen Zhang, Jiaxing Sun, Zeyuan Wang, Yu Wang, Xin Hao, Fei Gao, Xiaoqing Jiang. A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World DataFrontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.576901
23
Zhiting Lao, Shuanqi Li, Jinhui Liang, Jingyi Su, Xin Gong, Xiping Cui, Suqing Zhao. Production and characterization of GPC3-N protein and its nanobodyProtein Expression and Purification 2022; : 106094 doi: 10.1016/j.pep.2022.106094
24
Hong-Yang Li, Shi-Ji Zhou, Min Li, Ding Xiong, Akanand Singh, Qing-Xi Guo, Chang-An Liu, Jian-Ping Gong. Diagnosis and Cure Experience of Hepatolithiasis-Associated Intrahepatic Cholangiocarcinoma in 66 PatientsAsian Pacific Journal of Cancer Prevention 2012; 13(2): 725 doi: 10.7314/APJCP.2012.13.2.725
25
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
26
Johnathan Abou-Fade, Victoria Reid, Alexander Le, Jun Zhang. 2022;  doi: 10.32388/UFK906
27
Rondell P. Graham, Emily G. Barr Fritcher, Ekaterina Pestova, John Schulz, Leonid A. Sitailo, George Vasmatzis, Stephen J. Murphy, Robert R. McWilliams, Steven N. Hart, Kevin C. Halling, Lewis R. Roberts, Gregory J. Gores, Fergus J. Couch, Lizhi Zhang, Mitesh J. Borad, Benjamin R. Kipp. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinomaHuman Pathology 2014; 45(8): 1630 doi: 10.1016/j.humpath.2014.03.014
28
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a reviewBiomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048